This biotech stock fits the profile of a potentially big winner to a T.Fortunes have been made on biotech stocks over the last few decades. The secret to success has been to invest in an up-and-coming biotech company before it even had a product on the market. Ideally, the company would have a pipeline featuring multiple promising candidates with significant commercial potential.Viking Therapeutics (VKTX 0.52%) fits the profile of such a stock to a T. Could Viking be a millionaire-maker?What's in Viking The ...